Diana Harshbarger (R-TN)

Drug Shortage Compounding Patient Access Act of 2025

H.R. 5316 · House bill Health

A Republican bill with 3 Republican cosponsors · See all 3 cosponsors

Last activity — Referred to the House Committee on Energy and Commerce.

In committee

Introduced and handed to a committee in the chamber it started in.

The committee holds it, and most bills are never heard from again. A hearing or a committee vote would be news; silence is the usual outcome, and it kills the bill without anyone voting against it.

Its path through Congress

  1. Introduced
  2. In Committee

What this bill would do

The Drug Shortage Compounding Patient Access Act of 2025 aims to amend the Federal Food, Drug, and Cosmetic Act. It seeks to ensure patients can access certain medications during shortages or urgent-use situations. The bill allows licensed pharmacists or physicians to compound drugs for distribution to clinical settings for urgent administration. It also introduces new requirements for reporting drug shortages and surges in demand. Additionally, the bill updates regulations regarding outsourcing facilities and drug labeling.

Yes

  • Scored +7

    Does this make health care easier to get in general?

    The bill increases access to medications during shortages by allowing pharmacists and physicians to compound drugs for urgent clinical use.

  • Scored +5

    Does this make what the government does easier for the public to see?

    The bill requires the Secretary to make annual public updates regarding the evaluation of bulk drug substances.

The opposite

No question was scored the opposite.